“This is a dynamic time in our field, with many recent advances in the treatment of genitourinary (GU) cancers. The 2013 GU Cancers Symposium program will cover the spectrum of cancer research and care—from the cutting-edge bench research that leads to the best in clinical trials, to insights into what treatments we may be using in the next 2-5 years.” 

Christopher P. Evans, MD
UC Davis Health System
Steering Committee Member

If you attend one meeting this year, make it the GU Cancers Symposium. The greatest in GU oncology. 

Housing and Early Registration Deadline: January 9, 2013 at 11:59 PM (EST)